A. Jayaraj

Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model

A. Chakilam, Mitalee Tamhane, A. Jayaraj, 2010, Drug development and industrial pharmacy.

Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.

C. Price, J. Keirns, D. Hauss, 1998, Journal of pharmaceutical sciences.

Effect of thioacetamide-induced hepatic necrosis on the regioselective metabolism of S-warfarin by rat liver mixed-function oxidase enzymes.

W. R. Porter, A. Jayaraj, A. O. Obaseki, 1983, Biochemical pharmacology.

Rat and Rabbit Plasma Distribution of Free and Chylomicron-Associated BIRT 377, a Novel Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion

K. Wasan, D. Hauss, M. Ramaswamy, 2001, Pharmaceutical Research.

Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.

Xiaowei Jin, J. Linden, R. Petter, 2006, Journal of medicinal chemistry.

Metabolic activation of aflatoxin B1 by liver tissue from male Fischer F344 rats of various ages

A. Richardson, A. Jayaraj, 1981, Mechanisms of Ageing and Development.

The effect of testosterone treatment on the ability of female rat liver S9 to activate aflatoxin B1 and 2-aminofluorene in the AMES/Salmonella system.

A. Jayaraj, P. Chernesky, A. Richardson, 1982, Mutation research.

LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation.

C. Raab, M. Braun, D. Musson, 2002, Journal of pharmaceutical and biomedical analysis.

Metabolic activation of chemical carcinogens by kidney from rats and mice of various ages.

A. Jayaraj, M. A. Sutter, P. Chernesky, 1982, Comparative biochemistry and physiology. C: Comparative pharmacology.